Comparison of whole-cell versus acellular pertussis vaccine effectiveness in school clusters of pertussis, France, 2013

Med Mal Infect. 2020 Oct;50(7):617-619. doi: 10.1016/j.medmal.2020.07.004. Epub 2020 Jul 10.

Abstract

Objectives and method: We conducted a prospective study in 2013 to compare the whole-cell versus acellular pertussis vaccines effectiveness and duration of protection, following the occurrence of pertussis clusters.

Results: During seven school outbreaks, we identified 102 clinical pertussis cases, including 10 cases biologically confirmed by Bordetella pertussis specific PCR, among a cohort of 305 children in 2nd to 6th grade. The risk of pertussis when vaccinated with an acellular vaccine alone was 1.6 (RR=1.6; 95% CI=1.1-2.5) times higher than when vaccinated with a whole-cell vaccine or using a combined schedule.

Conclusions: The limited duration of protection conferred by the acellular vaccine reinforces the 2013 introduction of the pertussis booster at six years old.

Keywords: Acellular pertussis vaccine; Pertussis; School outbreaks; Vaccine effectiveness; Whole-cell pertussis vaccine.

Publication types

  • Comparative Study

MeSH terms

  • Child
  • Child, Preschool
  • Disease Outbreaks*
  • France / epidemiology
  • Humans
  • Infant
  • Pertussis Vaccine / immunology*
  • Prospective Studies
  • Schools
  • Vaccines, Acellular
  • Whooping Cough / epidemiology*
  • Whooping Cough / prevention & control*

Substances

  • Pertussis Vaccine
  • Vaccines, Acellular